NCT00108043

Brief Summary

Objective: The objective of this research is to undertake a safety and viability study of FES-evoked stepping in individuals with paraplegia. The rationale for this objective is based upon the need to clarify whether physiological limitations, especially orthostatic intolerance, limit functional mobility outcomes. The cardiovascular, autonomic, and muscle metabolic factors governing orthostatic tolerance during skin-surface FES stepping will be investigated, since this functional task forms the basis of upright mobility and engenders strong physiological challenges upon key regulatory processes in the SCI (spinal cord injury) patient. Specific Hypotheses: i. Reduction of blood pressure will be greater during FES-evoked stepping than during passive stepping; ii. Reduction of blood pressure will be greater during FES-evoked stepping with no upper body component versus FES-stepping with an upper body component; iii. Blood pressure will be reduced even further during FES-evoked stepping following a 6-week progressive-intensity gait training intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for phase_1

Timeline
Completed

Started Mar 2004

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2004

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

April 12, 2005

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 13, 2005

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2006

Completed
Last Updated

December 3, 2015

Status Verified

December 1, 2015

First QC Date

April 12, 2005

Last Update Submit

December 2, 2015

Conditions

Keywords

Functional Electrical StimulationGaitBlood pressureOrthostatic HypotensionCardiovascular responsesNear-infra red spectroscopy

Outcome Measures

Primary Outcomes (1)

  • Change of systolic blood pressure during three FES-evoked stepping conditions

Secondary Outcomes (5)

  • Cardiovascular and Metabolic Responses

  • Autonomic Responses

  • Muscle Metabolic Responses

  • Humoral Responses

  • Syncope Symptom Score

Interventions

Eligibility Criteria

Age18 Years - 55 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Male
  • A spinal cord lesion, of traumatic etiology, between the 6th and 11th thoracic spinal segments
  • Sensory and motor complete lesion (ASIA \[American Spinal Injury Association\]-A)
  • At least 2 years post injury
  • Between 18-55 years of age
  • Responsive to electrical stimulation

You may not qualify if:

  • Severe osteoporosis, fractures, dislocations (as determined by X-ray and DEXA)
  • Upper limb or shoulder pathologies
  • Severe spasticity (≥4 on Ashworth scale)
  • Contractures
  • Currently undertaking FES or gait training

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rehabilitation Research Centre, University of Sydney

Sydney, New South Wales, 2141, Australia

Location

MeSH Terms

Conditions

Spinal Cord InjuriesHypotension, Orthostatic

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesOrthostatic IntolerancePrimary DysautonomiasAutonomic Nervous System DiseasesHypotensionVascular DiseasesCardiovascular Diseases

Study Officials

  • Glen M Davis, PhD, FACSM

    University of Sydney

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 12, 2005

First Posted

April 13, 2005

Study Start

March 1, 2004

Study Completion

December 1, 2006

Last Updated

December 3, 2015

Record last verified: 2015-12

Locations